Biohit Oyj (LTS:0DRP) Beneish M-Score: -1.23 (As of Jun. 26, 2026)


LTS:0DRP Biohit Oyj LTS:0DRP
78 GF Score
Price €2.47
GF Value €2.69
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Biohit Oyj Beneish M-Score?

Biohit Oyj LTS:0DRP -2.95% 78 Beneish M-Score is -1.23 as of Jun. 26, 2026. GuruFocus rates LTS:0DRP with a GF Score™ of 78/100 and a GF Value™ of €2.69 (Fairly Valued). The stock has 4 warning signs investors should review. Among 766 Medical Devices & Instruments companies, Biohit Oyj ranks worse than 89.3% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score -1.23 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Biohit Oyj's Beneish M-Score or its related term are showing as below:

LTS:0DRP' s Beneish M-Score Range Over the Past 10 Years
Min: -4.6   Med: -2.51   Max: 1.63
Current: -1.23

During the past 13 years, the highest Beneish M-Score of Biohit Oyj was 1.63. The lowest was -4.60. And the median was -2.51.


Biohit Oyj Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Biohit Oyj's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biohit Oyj Beneish M-Score Chart

Biohit Oyj Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.66 -3.00 -1.17 1.63 -1.23

Biohit Oyj Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.17 0.00 1.63 0.00 -1.23

LTS:0DRP vs ABT, SYK, MDT: Beneish M-Score Comparison

For the Medical Devices subindustry, Biohit Oyj's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biohit Oyj Beneish M-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biohit Oyj's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Biohit Oyj's Beneish M-Score falls into.


LTS:0DRP
78GF Score
Biohit Oyj LTS:0DRP
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biohit Oyj Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Biohit Oyj for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0169+0.528 * 0.957+0.404 * 1.7703+0.892 * 1.1014+0.115 * 1.7927
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0263+4.679 * 0.175998-0.327 * 1.1529
=-1.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was €3.60 Mil.
Revenue was €15.73 Mil.
Gross Profit was €10.75 Mil.
Total Current Assets was €9.25 Mil.
Total Assets was €19.81 Mil.
Property, Plant and Equipment(Net PPE) was €1.86 Mil.
Depreciation, Depletion and Amortization(DDA) was €0.41 Mil.
Selling, General, & Admin. Expense(SGA) was €0.62 Mil.
Total Current Liabilities was €3.61 Mil.
Long-Term Debt & Capital Lease Obligation was €1.25 Mil.
Net Income was €2.74 Mil.
Gross Profit was €0.00 Mil.
Cash Flow from Operations was €-0.75 Mil.
Total Receivables was €3.21 Mil.
Revenue was €14.28 Mil.
Gross Profit was €9.34 Mil.
Total Current Assets was €10.95 Mil.
Total Assets was €15.50 Mil.
Property, Plant and Equipment(Net PPE) was €0.70 Mil.
Depreciation, Depletion and Amortization(DDA) was €0.34 Mil.
Selling, General, & Admin. Expense(SGA) was €0.55 Mil.
Total Current Liabilities was €3.02 Mil.
Long-Term Debt & Capital Lease Obligation was €0.28 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(3.6 / 15.732) / (3.214 / 14.283)
=0.228833 / 0.225023
=1.0169

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(9.339 / 14.283) / (10.749 / 15.732)
=0.653854 / 0.683257
=0.957

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (9.247 + 1.856) / 19.807) / (1 - (10.952 + 0.702) / 15.502)
=0.439441 / 0.248226
=1.7703

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=15.732 / 14.283
=1.1014

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0.341 / (0.341 + 0.702)) / (0.414 / (0.414 + 1.856))
=0.326942 / 0.182379
=1.7927

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0.624 / 15.732) / (0.552 / 14.283)
=0.039664 / 0.038647
=1.0263

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((1.251 + 3.613) / 19.807) / ((0.284 + 3.018) / 15.502)
=0.24557 / 0.213005
=1.1529

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(2.738 - 0 - -0.748) / 19.807
=0.175998

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Biohit Oyj has a M-score of -1.23 signals that the company is likely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -1.23 mean?
Biohit Oyj (LTS:0DRP) has a Beneish M-Score of -1.23 as of Jun. 26, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Biohit Oyj and its competitors. According to the industry distribution chart, Biohit Oyj ranks #684 out of 766 companies in the Medical Devices & Instruments industry, placing it in the top 89.3%.
Is Biohit Oyj's Beneish M-Score too high?
Biohit Oyj's current Beneish M-Score is -1.23. Based on the distribution chart, Biohit Oyj ranks #684 out of 766 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Biohit Oyj has a GF Score™ of 78/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Biohit Oyj's Beneish M-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Biohit Oyj ranks #684 out of 766 companies for Beneish M-Score. This places Biohit Oyj in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Devices & Instruments company?
A good Beneish M-Score depends on the Medical Devices & Instruments industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Biohit Oyj and its competitors. Biohit Oyj's current Beneish M-Score is -1.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biohit Oyj stock overvalued right now?
Based on GuruFocus' analysis, Biohit Oyj (LTS:0DRP) is currently considered Fairly Valued. The stock's GF Value™ is €2.69, compared to a current price of €2.47 — trading 8.4% below its estimated fair value. The current Beneish M-Score is -1.23. Biohit Oyj's overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Biohit Oyj (LTS:0DRP), the current Beneish M-Score is -1.23 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biohit Oyj (LTS:0DRP) Overvalued in 2026?

Based on GuruFocus' analysis, Biohit Oyj stock appears to be undervalued. The current stock price of €2.47 is trading 8.4% below its estimated GF Value™ of €2.69. GuruFocus considers Biohit Oyj to be Fairly Valued.

Key valuation signals for LTS:0DRP:

  • Beneish M-Score: -1.23
  • GF Value™: €2.69 vs. price of €2.47 (8.4% below fair value)
  • GF Score™: 78/100 with 4 warning signs

No single metric tells the full story. See the LTS:0DRP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Biohit Oyj Business Description

Other Exchanges BIOBV:Finland
Address Laippatie 1, Helsinki, FIN, 00880
Biohit Oyj is a globally operating Finnish biotechnology company that develops diagnostic and other health products. Its products include GastroPanel quick test assesses the structure and function of the stomach lining; ColonView quick test is an immunochemical fecal occult blood test (FIT) developed; Acetium capsules protect the stomach lining from carcinogenic acetaldehyde, especially in people with acid-free stomachs. The company's product portfolio consists of diagnostic tests, analysis systems, products binding carcinogenic acetaldehyde into a harmless compound and monoclonal antibodies.
78GF Score

Get the complete analysis for LTS:0DRP

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.47
Price
€2.69
GF Value